Wordt geladen...
Integrating BRAF/MEK inhibitors into combination therapy for melanoma
The discovery of BRAF mutations in melanoma has not yet translated into clinical success, suggesting that BRAF/MEK inhibitors will need to be combined with other agents. In the current review, we discuss other pathways likely to be important for melanoma progression and suggest possible drug combina...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2658537/ https://ncbi.nlm.nih.gov/pubmed/19156138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604891 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|